Medical News

RSS

Tailored ACT+ may address psychological and supportive-care for cancer survivors

Advances in early diagnosis and cancer treatment mean that growing numbers of people are surviving cancer, with approximately 3.5 million people now living with and beyond the disease in the United Kingdom.

29 Sep 2026

Exercise therapy reduces knee osteoarthritis risk after ACL surgery

Exercise-based rehabilitation and education can reduce the chance of knee osteoarthritis following ACL reconstruction in people aged under 40, as well as improve pain and quality of life, a study by La Trobe University researchers has found.

29 Sep 2026

Blood tests can identify cancer neoantigens for personalized immunotherapy

Cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells, respectively, and they largely matched those found through traditional tumor tissue biopsy in many patients.

29 Sep 2026

Can’t stop thinking about food? You’re far from alone

Investigating 'food noise', this study reveals its association with diet quality and mental health, emphasizing demographic influences and eating behaviors.

29 Sep 2026

Late diagnosis and systemic gaps drive high cancer death rates in the Balkans

In the Balkans, cancer survival rates lag due to late diagnoses and weak screening programs, highlighting the need for improved early detection strategies.

From BGI Genomics 29 Sep 2026

What makes some teens more open in online conversations?

Stronger Theory of Mind in adolescents links to increased online conversations and self-disclosure, revealing complex dynamics in digital communication.

29 Sep 2026

Now measurable in plasma: eMTBR-Tau

Tau tangles are closely linked to Alzheimer’s disease progression. But the tau species associated with these aggregates are present at exceptionally low levels in blood, making them difficult to measure.

From Spear Bio 29 Sep 2026

Asynt adds overhead stirring to PressureSyn for more demanding high-pressure chemistry

The updated modular PressureSyn introduces an optional overhead stirring manifold, addressing a limitation of magnetic stirring in demanding high-pressure reactions: as viscosity or solids content increases, magnetic coupling can lose consistent contact with the stir bar, leading to unreliable mixing.

From Asynt 29 Sep 2026

From wild rice to tarwi, researchers are exploring the health potential of Indigenous foods

A conference paper reviewed North American and Andean Indigenous foods, including Three Sisters crops, wild rice, native berries, tarwi, quinoa, and amaranth, and described their nutrients and bioactive compounds. Evidence for health effects remains limited for many of these foods, and the authors call for research developed with Indigenous communities that also supports traditional knowledge and food sovereignty.

28 Sep 2026

Experimental mRNA therapy protects the liver after acetaminophen overdose

When a patient arrives at the hospital with an acetaminophen overdose, it's often a race against the clock. The only FDA-approved antidote for overdose-related liver injury, N‑acetylcysteine, must be administered within hours to be effective.

28 Sep 2026

From espresso to filter coffee, brewing may shape what reaches your gut

A focused narrative review traces how caffeine, chlorogenic acids, and coffee fibers move through the gut and interact with microbes. The authors identify plausible links between the microbiome and liver health, but human studies have not shown that microbiome changes cause coffee’s reported metabolic benefits.

28 Sep 2026

An approved Ebola antibody may miss its mark against Bundibugyo virus

Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the virus’s glycoprotein. The models predicted disrupted binding for Ebanga, conserved targets for MBP134, and different binding behavior for the complete Inmazeb cocktail than for two of its antibodies alone; laboratory tests are needed to determine whether these findings translate into treatment benefit.

28 Sep 2026

Five-session SBRT preserves quality of life before pancreatic cancer surgery

Patients preparing for pancreatic cancer surgery maintained better physical function and experienced less fatigue with five treatments of stereotactic body radiation therapy (SBRT) than with 28 treatments of conventional radiation therapy given with chemotherapy, according to a randomized phase 2 clinical trial.

28 Sep 2026

Blood markers linked to healthy eating may reflect more than food choices

Researchers analyzed dietary data from 204,938 UK Biobank participants and identified blood protein and metabolite profiles associated with adherence to the EAT-Lancet diet. These profiles showed stronger links to several health outcomes and modeled life expectancy than the diet score, but the observational study cannot establish that the diet caused those differences.

28 Sep 2026

Shoppers valued healthier, greener foods, but still chose meat

In a discrete choice experiment involving 272 Dutch adults, researchers examined how people valued meat, meat replacers, and legumes across pasta and traditional potatoes-meat-vegetables meals. Health and sustainability labels ranked highly, but participants still tended to favor meat when measured product attributes were held constant, with only modest differences across meal settings.

28 Sep 2026

Five-treatment radiation provides excellent long-term prostate cancer control

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in the first randomized trial to directly compare the treatments for localized prostate cancer.

28 Sep 2026

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

HR+/HER2− breast cancer constitutes approximately 65–75% of all breast cancer cases worldwide. Although CDK4/6 inhibitors have substantially extended progression-free survival (PFS), up to 60% of patients derive no clinical benefit from these agents, underscoring the urgent need for more effective therapeutic strategies.

28 Sep 2026

Banning ultra-processed foods brings major hurdles for public schools

Starting in July 2029, public schools are required to start phasing out ultra-processed foods under a new California law that prohibits schools from serving foods high in sugar, fat, salt and certain artificial food additives.

28 Sep 2026

Focused radiosurgery extends survival for small cell lung cancer patients with brain metastases

Patients with small cell lung cancer (SCLC) that had spread to the brain lived a median of 17 months after focused stereotactic radiosurgery, compared with nine months after an advanced form of whole brain radiation therapy, an unexpected secondary finding from the first randomized phase 3 trial to compare the treatment approaches in this population.

28 Sep 2026